COMMUNIQUÉS West-GlobeNewswire

-
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
29/04/2024 -
Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024
29/04/2024 -
Transactions in Connection with Share Buy-back Program Genmab
29/04/2024 -
ENA Respiratory Announces FDA IND Clearance for its Prophylactic Intranasal INNA-051 - a First-in-Class Antiviral Innate Immunomodulator
29/04/2024 -
Calibre Scientific Acquires Camlab Limited, a UK Provider of Scientific Equipment, Chemicals, Consumables and Other Laboratory Supplies
29/04/2024 -
Burning Rock Publishes 2023 Annual Report on Form 20-F
29/04/2024 -
Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officer
29/04/2024 -
Olansi Healthcare Co., Ltd Redefines home water solutions with its best countertop water purifiers, hot and cold RO water purifiers and hot/cold water dispensers
29/04/2024 -
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
29/04/2024 -
Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023
29/04/2024 -
Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion
29/04/2024 -
Ibogaine By David Dardashti Appoints Whitney Nuckolls for Aftercare Support for Women
28/04/2024 -
Financière de Tubize - Dividend approval
27/04/2024 -
Financière de Tubize - Approbation du dividende
27/04/2024 -
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
27/04/2024 -
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
27/04/2024 -
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
26/04/2024 -
BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board of Directors
26/04/2024 -
Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26/04/2024
Pages